Drugs / N-acetyl cysteine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05840640 | Oct 2017 → Feb 2021 | alcoholic hepatitis | Post Graduate Institute of Medical Education and Research, Chandigarh | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N-acetyl cysteine | “The effect on glutathione replenishing potential by N-acetyl cysteine (NAC) can be used to reduce oxidative stress” NCT05840640 ↗ |
| Known as | NAC | “Standard Medical Therapy plus G-CSF with intravenous NAC (day 1: NAC at 150, 50, and 100 mg/kg in 250, 500, and 1000 ml of 5% glucose solution over 30 minutes, 4 hours, and 16...” NCT05840640 ↗ |
| Route | Intravenous | “intravenous NAC” NCT05840640 ↗ |